JP2023547883A5 - - Google Patents
Info
- Publication number
- JP2023547883A5 JP2023547883A5 JP2023525008A JP2023525008A JP2023547883A5 JP 2023547883 A5 JP2023547883 A5 JP 2023547883A5 JP 2023525008 A JP2023525008 A JP 2023525008A JP 2023525008 A JP2023525008 A JP 2023525008A JP 2023547883 A5 JP2023547883 A5 JP 2023547883A5
- Authority
- JP
- Japan
- Prior art keywords
- csf
- item
- recombinant human
- cells
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063105425P | 2020-10-26 | 2020-10-26 | |
| US63/105,425 | 2020-10-26 | ||
| US202163177481P | 2021-04-21 | 2021-04-21 | |
| US63/177,481 | 2021-04-21 | ||
| PCT/US2021/056413 WO2022093671A1 (en) | 2020-10-26 | 2021-10-25 | Granulocyte macrophage-colony stimulating factor mutants |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023547883A JP2023547883A (ja) | 2023-11-14 |
| JP2023547883A5 true JP2023547883A5 (https=) | 2024-11-06 |
Family
ID=81383210
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023525008A Pending JP2023547883A (ja) | 2020-10-26 | 2021-10-25 | 顆粒球マクロファージコロニー刺激因子変異体 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240182535A1 (https=) |
| EP (1) | EP4232067A4 (https=) |
| JP (1) | JP2023547883A (https=) |
| CA (1) | CA3196431A1 (https=) |
| WO (1) | WO2022093671A1 (https=) |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5391485A (en) * | 1985-08-06 | 1995-02-21 | Immunex Corporation | DNAs encoding analog GM-CSF molecules displaying resistance to proteases which cleave at adjacent dibasic residues |
| US5032676A (en) * | 1986-10-14 | 1991-07-16 | Immunex Corporation | Nonglycosylated analogs of human colony stimulating factors |
| EP0276846A3 (en) * | 1987-01-29 | 1989-07-26 | Zymogenetics, Inc. | Colony-stimulating factor derivatives |
| WO1988005786A1 (en) * | 1987-02-06 | 1988-08-11 | Genetics Institute, Inc. | Colony stimulating factors having reduced levels of carbohydrate |
| JPH03502322A (ja) * | 1987-10-30 | 1991-05-30 | イミュネックス・コーポレーション | ヒトコロニー形成刺激因子の非グリコシル化類似体 |
| JPH02152995A (ja) * | 1988-07-08 | 1990-06-12 | Sumitomo Chem Co Ltd | ヒト顆粒球・マクロファージコロニー刺激因子の分離精製法 |
| ATE210182T1 (de) * | 1993-06-30 | 2001-12-15 | Lucky Ltd | Modifizierte-granulocyte-makrophage-kolonie- stimulierender-faktor-gen und seine expression in hefe |
| ES2297889T3 (es) * | 1997-07-14 | 2008-05-01 | Bolder Biotechnology, Inc. | Derivados de hormona de crecimiento y proteinas relacionadas. |
| US20080076706A1 (en) * | 1997-07-14 | 2008-03-27 | Bolder Biotechnology, Inc. | Derivatives of Growth Hormone and Related Proteins, and Methods of Use Thereof |
| US20040091995A1 (en) * | 2001-06-15 | 2004-05-13 | Jeffrey Schlom | Recombinant non-replicating virus expressing gm-csf and uses thereof to enhance immune responses |
| DE60332358D1 (de) * | 2002-09-09 | 2010-06-10 | Hanall Pharmaceutical Co Ltd | Protease-resistente modifizierte interferon alpha polypeptide |
| WO2006079169A1 (en) * | 2005-01-25 | 2006-08-03 | Apollo Life Sciences Limited | Parameter selected gm-csf, il-3, il-4, il-5 and chimeras thereof for therapeutic and diagnostic purposes |
| US9320777B2 (en) * | 2011-05-13 | 2016-04-26 | Bolder Biotechnology, Inc. | Methods and use of growth hormone supergene family protein analogs for treatment of radiation exposure |
-
2021
- 2021-10-25 WO PCT/US2021/056413 patent/WO2022093671A1/en not_active Ceased
- 2021-10-25 US US18/033,252 patent/US20240182535A1/en active Pending
- 2021-10-25 CA CA3196431A patent/CA3196431A1/en active Pending
- 2021-10-25 EP EP21887248.9A patent/EP4232067A4/en active Pending
- 2021-10-25 JP JP2023525008A patent/JP2023547883A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6499592B2 (ja) | Ｂ型肝炎ワクチン | |
| US20120045445A1 (en) | Method of treating viral diseases | |
| Silin et al. | Synthetic and natural immunomodulators acting as interferon inducers | |
| ES2329204T3 (es) | Composicion antiviral que comprende interferon en forma de gotas nasales. | |
| RU2003104525A (ru) | Применение штаммов вируса parapox ovis для получения антивирусных и противораковых лекарственных средств | |
| JP2023547883A5 (https=) | ||
| Balsari et al. | Natural antibodies to IL-2 | |
| Huang et al. | Protective effects of recombinant human granulocyte macrophage colony stimulating factor on H1N1 influenza virus-induced pneumonia in mice | |
| JP2022513438A5 (https=) | ||
| CN106834226A (zh) | 一种体外免疫细胞制剂的修饰方法及其应用 | |
| CN112843092B (zh) | 免疫细胞在治疗疾病中的应用及其制备方法 | |
| JP2023553117A5 (https=) | ||
| JP2014510126A5 (ja) | Ｉｆｎアルファ関連疾病の処置方法 | |
| EP4159233A1 (en) | Pharmaceutical composition comprising polynucleotides and use thereof for prevention or treatment of covid-19 | |
| CN115925823A (zh) | SARS-CoV-2编码蛋白来源的T细胞表位多肽FAFPFTIYSL及其应用 | |
| EP0351876A2 (en) | Composition for potentiating vaccination effect | |
| WO2021198346A2 (en) | Ezrin peptide 1 for use in a method of treating covid-19 | |
| CN112386688B (zh) | 一种用于病毒治疗的含有免疫细胞的药物组合物 | |
| Li | Advances in the study of cytokine storm mechanisms in pneumonia: An example of IL-6 and IL-33 | |
| ES2736503T3 (es) | Nuevos análogos de la proteína IFN beta | |
| Assi et al. | Investigational immunomodulatory therapies for COVID-19 | |
| EP4125996B1 (en) | Ezrin peptide 1 for use in a method of treating covid-19 | |
| RU2242243C2 (ru) | Композиции и способы потенцирования терапевтических эффектов интерферонов | |
| CA3212362A1 (en) | Ezrin peptide 1 for use in a method of treating post covid-19 | |
| RU2017126043A (ru) | Композиция от бешенства, содержащая адъювант pika |